New Medicine Service — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Offer support through the New Medicine Service if the patient is eligible and consents
NMS can support adherence and technique for eligible long-term medicines with consent. In this scenario, the pharmacist should prioritise safe supply, appropriate counselling and timely referral or clarification where needed. This is the single best answer because the other options would either delay assessment, ignore a clinically significant risk, or create an unsafe legal or professional outcome.
Reference: NHS Community Pharmacy Contractual Framework; MEP